Diagnostic Yield of Acid Fast Bacilli in Bronchoalveolar Lavage of Sputum-Negative Pulmonary Tuberculosis Patients

Authors

  • Tehreem Zulfiqar Janjua Department of Pulmonology, Gulab Devi hospital, Lahore, Pakistan
  • Saqib Musharaf Department of Pulmonology, Gulab Devi hospital, Lahore, Pakistan
  • Arooba Zulfiqar Janjua Benazir Bhutto Shaheed Hospital Abbottabad, Pakistan
  • Faisal Hassan Zahid Chaudhery Department of Pulmonology, Gulab Devi hospital, Lahore, Pakistan
  • Farzeen Bakhtawar Department of Pulmonology, Gulab Devi hospital, Lahore, Pakistan
  • Anum Ashraf Department of Pulmonology, Gulab Devi hospital, Lahore, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i4.1633

Keywords:

Bronchoalveolar lavage, Pulmonary tuberculosis, Sputum Negative

Abstract

Pulmonary tuberculosis (PTB) remains a significant public health concern, especially in high-burden countries like Pakistan. Diagnosis becomes particularly challenging in sputum-negative patients, leading to delayed treatment and increased transmission. Bronchoalveolar lavage (BAL) has emerged as a potential diagnostic tool in such cases. Objective: To determine the diagnostic yield of acid-fast bacilli (AFB) in bronchoalveolar lavage of sputum-negative pulmonary tuberculosis patients. Methods: This cross-sectional study was conducted in the Department of Pulmonology, Gulab Devi Hospital, Lahore, over six months from June to December 2024. One hundred fifty sputum-negative PTB patients undergoing BAL were enrolled through consecutive sampling. BAL samples were collected and sent to the pathology laboratory for AFB testing via Ziehl-Neelsen staining. The primary outcome was the proportion of positive AFB results among the study population. Data were analyzed using SPSS version 25. Chi-square test was applied to assess associations between diagnostic yield and demographic or clinical variables; a p-value < 0.05 was considered statistically significant. Results: Among 150 patients, 71.3% (n = 107) were male; the mean age was 42.81 ± 11.23 years. Most participants (72.0%) were aged ≤45 years. A majority (68.0%) resided in rural areas, and 62.7% belonged to a low socioeconomic status. Comorbidities included diabetes (32.7%), hypertension (40.7%), and obesity (9.3%). The mean disease duration was 2.36 ± 1.09 months, with 80.7% having symptoms for ≤3 Months. Family history of TB and smoking history were noted in 26.0% and 22.0%, respectively. Most patients were unskilled workers (47.3%) or housewives (24.0%). The diagnostic yield of BAL for AFB was 83.3% (n = 125). Diagnostic yield was significantly associated with gender (p < 0.05), residential status (p < 0.05), disease duration (p < 0.05), and occupation (p < 0.05). Conclusion: Bronchoalveolar lavage demonstrates a high diagnostic yield for AFB in sputum-negative PTB patients and should be incorporated as a standard diagnostic modality in suspected cases. Early and accurate diagnosis through BAL can facilitate timely management, reduce disease transmission, and improve patient outcomes, particularly in resource-limited settings.

Downloads

Download data is not yet available.

References

Rakha MA, Ali A, Hassan W, Al-Anbay E. GeneXpert analysis of bronchoalveolar lavage (BAL) samples: promising diagnostic modality in patients with smear-negative pulmonary tuberculosis. The Egyptian Journal of Bronchology. 2022;16(1):68.

Koraa EE-DA, Abdel-Fattah EB, El-Touny RM. Diagnostic yield of bronchoalveolar lavage GeneXpert in smear-negative and sputum-scarce pulmonary tuberculosis. The Egyptian Journal of Chest Diseases and Tuberculosis. 2021;70(4):469-73.

Dhakal SS, Neupane A, Chaudhary S, Mishra N, Karki DB. Utility of Bronchoalveolar Lavage in the Diagnosis of Sputum Negative Pulmonary Tuberculosis. Journal of Universal College of Medical Sciences. 2020;8(1):19-22.

Uddin MKM, Ather MF, Akter S, Nasrin R, Rahman T, Kabir SN, et al. Diagnostic Yield of Xpert MTB/RIF Assay Using Bronchoalveolar Lavage Fluid in Detecting Mycobacterium tuberculosis among the Sputum-Scarce Suspected Pulmonary TB Patients. Diagnostics. 2022;12(7):1676.

Nikbakhsh N, Bayani M, Siadati S. The Value of Bronchoalveolar Lavage in the Diagnosis of Sputum Smear-NegativePulmonary Tuberculosis. Iranian journal of pathology. 2015;10(1):35-40.

Brito GMX, Mafort TT, Ribeiro-Alves M, Reis LVTD, Leung J, Leão RS, Rufino R, Rodrigues LS. Diagnostic performance of the Xpert MTB/RIF assay in BAL fluid samples from patients under clinical suspicion of pulmonary tuberculosis: a tertiary care experience in a high-tuberculosis-burden area. J Bras Pneumol. 2021 May 17;47(2):e20200581. doi: 10.36416/1806-3756/e20200581. PMID: 34008762; PMCID: PMC8332835.

Iúdice TNDS, da Conceição ML, de Brito AC, de Souza NM, Mesquita CR, Guimarães RJPSE, Furlaneto IP, Saboia AS, Lourenço MCDS, Lima KVB, Conceição EC. The Role of GeneXpert® for Tuberculosis Diagnostics in Brazil: An Examination from a Historical and Epidemiological Perspective. Trop Med Infect Dis. 2023 Oct 26;8(11):483. doi: 10.3390/tropicalmed8110483. PMID: 37999602; PMCID: PMC10674801.

Villalva-Serra K, Barreto-Duarte B, Miguez-Pinto JP, Queiroz ATL, Rodrigues MM, Rebeiro PF, Amorim G, Cordeiro-Santos M, Sterling TR, Araújo-Pereira M, Andrade BB. Impact of Xpert MTB/RIF implementation in tuberculosis case detection and control in Brazil: a nationwide intervention time-series analysis (2011-2022). Lancet Reg Health Am. 2024 Jun 5;36:100804. doi: 10.1016/j.lana.2024.100804. PMID: 38912329; PMCID: PMC11192787.

Conceição EC, Loubser J, Guimarães AEDS, Sharma A, Rutaihwa LK, Dippenaar A, Salvato RS, de Paula Souza E Guimarães RJ, da Silva Lourenço MC, Barros WA, Cardoso NC, Warren RM, Gagneux S, Grinsztejn BGJ, Suffys PN, Lima KVB. A Genome-Focused Investigation Reveals the Emergence of a Mycobacterium tuberculosis Strain Related to Multidrug-Resistant Tuberculosis in the Amazon Region of Brazil. Microorganisms. 2024 Sep 2;12(9):1817. doi: 10.3390/microorganisms12091817. PMID: 39338491; PMCID: PMC11434004.

Shibabaw A, Gelaw B, Ghanem M, Legall N, Schooley AM, Soehnlen MK, Salvador LCM, Gebreyes W, Wang SH, Tessema B. Molecular epidemiology and transmission dynamics of multi-drug resistant tuberculosis strains using whole genome sequencing in the Amhara region, Ethiopia. BMC Genomics. 2023 Jul 17;24(1):400. doi: 10.1186/s12864-023-09502-2. PMID: 37460951; PMCID: PMC10351181.

Zhu N, Zhou D, Xiong W, Zhang X, Li S. Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients. Front Cell Infect Microbiol. 2023 Oct 31;13:1271853. doi: 10.3389/fcimb.2023.1271853. PMID: 38029249; PMCID: PMC10644336.

Li C, Sun L, Liu Y, Zhou H, Chen J, She M, Wang Y. Diagnostic value of bronchoalveolar lavage fluid galactomannan assay for invasive pulmonary aspergillosis in adults: A meta-analysis. J Clin Pharm Ther. 2022 Dec;47(12):1913-1922. doi: 10.1111/jcpt.13792. Epub 2022 Nov 2. PMID: 36324286.

Imtiaz S, Batubara EM. Diagnostic value of bronchoscopy in sputum-negative pulmonary tuberculosis patients and its correlation with clinicoradiological features. Annals of thoracic medicine. 2022;17(2):124-31.

Pokharel A, Bhandari C, Sharma B, Bhandari R, Paudel Y. Diagnostic Value of Bronchoalveolar Lavage in Sputum-Smear Negative Pulmonary Tuberculosis. Journal of National Heart and Lung Society Nepal. 2023 Dec 31;2(2):77-80.

Hu X, Jiang L, Liu X, Chang H, Dong H, Yan J, Zhou X, Kong M. The diagnostic value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in critically ill patients with respiratory tract infections. Microbiology Spectrum. 2024 Aug 6;12(8):e00458-24.

Alam M, Shahzad MI, Pervaiz S, Jamil M, Afzal MW, Mushtaq A. Comparison of Induced Sputum with Bronchoalveolar Lavage Samples for Pulmonary Tuberculosis diagnosis in sputum scarce Patients. Pak J Chest Med 2020; 26 (3):140-144.

Koraa EA, Eman BA, Rana EM.Diagnostic yield of bronchoalveolar lavage GeneXpert in smear-negative and sputum-scarce pulmonary tuberculosis. Egyptian J Chest Dis Tuber. 2021;70(4):469-73.DOI: 10.4103/ecdt.ecdt_29_21.

Ahmad M, Ibrahim WH, Sarafandi SA, Shahzada KS, Ahmed S, Haq IU, Raza T, et al. Diagnostic value of bronchoalveolar lavage in the subset of patients with negative sputum/smear and mycobacterial culture and a suspicion of pulmonary tuberculosis. Int J Infect Dis. 2019 May;82:96-101. doi: 10.1016/j.ijid.2019.03.021. Epub 2019 Mar 20. PMID: 30904678.

Gaude GS, Samskruti S, Hattiholi J, Patil B. Diagnostic Yield of Bronchoalveolar lavage Xpert MTB/RIF Assay (Gene Xpert® in Sputum Smear Negative Pulmonary Tuberculosis Patients–A One Year Cross Sectional Study. SAARC J Tubercul, Lung Dis HIV/AIDS. 2019 Dec 31;17(2):1-7.

Ahammed S, Sarker MS, Ali MZ. Diagnostic Value of Bronchoalveolar Lavage Examination in Sputum Negative Patients for AFB in Suspected Pulmonary Tuberculosis. KYAMC Journal. 2021 Sep 6;12(2):84-7.

Downloads

Published

2025-04-30

How to Cite

Janjua, T. Z. ., Musharaf, S. ., Janjua, A. Z., Chaudhery, F. H. Z. ., Bakhtawar, F. ., & Ashraf, A. . (2025). Diagnostic Yield of Acid Fast Bacilli in Bronchoalveolar Lavage of Sputum-Negative Pulmonary Tuberculosis Patients. Biological and Clinical Sciences Research Journal, 6(4), 62–65. https://doi.org/10.54112/bcsrj.v6i4.1633

Issue

Section

Original Research Articles